Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease
MetadatosMostrar el registro completo del ítem
AutorMoleón González, María del Carmen; Martínez Gómez, Estrella; Flook, Marisa; Peralta-Leal, Andreína; Gallego, Juan Antonio; Sánchez Gómez, Hortensia; Alharilla Montilla Ibáñez, Maria de; Dominguez Durán, Emilio; Soto Varela, Andrés; Aran, Ismael; Frejo, Lidia; López Escámez, José Antonio
Hearing lossVértigoMigraineCytokinesInflammationVestibular disorders
Moleon, M.-D.-C.; Martinez-Gomez, E.; Flook, M.; Peralta-Leal, A.; Gallego, J.A.; Sanchez-Gomez, H.; Montilla-Ibañez, M.A.; Dominguez-Durán, E.; Soto-Varela, A.; Aran, I.; et al. Clinical and Cytokine Profile in Patients with Early and Late Onset Meniere Disease. J. Clin. Med. 2021, 10, 4052. https:// doi.org/10.3390/jcm10184052
PatrocinadorISCIII and European Regional Funds (Grants PI17/01644 and PI20/01126); Andalusian Health Government (Grant PE-0356-2018).; Andalusian Health Government (Grant PI-0027-2020).
Background: Meniere disease (MD) is an inner ear disorder associated with comorbidities such as autoimmune diseases or migraine. This study describes clinical and cytokine profiles in MD according to the age of onset of the condition. Methods: A cross-sectional study including 83 MD patients: 44 with early-onset MD (EOMD, <35 years old), and 39 with late-onset MD (LOMD, >50 years old), 64 patients with migraine and 55 controls was carried out. Clinical variables and cytokines levels of CCL3, CCL4, CCL18, CCL22, CXCL,1 and IL-1β were compared among the different groups. Results: CCL18 levels were higher in patients with migraine or MD than in controls. Elevated levels of IL-1β were observed in 11.4% EOMD and in 10.3% LOMD patients and these levels were not dependent on the age of individuals. EOMD had a longer duration of the disease (p = 0.004) and a higher prevalence of migraine than LOMD (p = 0.045). Conclusions: Patients with EOMD have a higher prevalence of migraine than LOMD, but migraine is not associated with any cytokine profile in patients with MD. The levels of CCL18, CCL3, and CXCL4 were different between patients with MD or migraine and controls.